You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ)一季度淨利潤預增50%-60%
格隆匯 03-28 16:30

格隆匯 3 月 28日丨迪瑞醫療(300396.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤5693.81萬元-6073.39萬元,同比增長50%-60%。業績變動原因如下:

1報吿期內國內新冠疫情緩解,醫院樣本量增加,2020年先後投入以免疫為主的儀器產品,對試劑銷售起到帶動作用。公司以自產和代理產品組成儀器加試劑新冠檢測組合套裝,國際市場銷售同比上漲明顯。此外,公司應對市場積極變化,加大了營銷投入致使收入有所上漲,歸屬於上市公司股東的淨利潤同比上升。

2報吿期內,預計2021第一季度非經常性損益對淨利潤的影響金額170萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account